대한천식알레르기학회 설하면역요법 진료지침
Allergen immunotherapy (AIT) has been used for over a century and has been demonstrated to be effective in treating patients with various allergic diseases. AIT allergens can be administered through various routes, including subcutaneous, sublingual, intra-lymphatic, oral, or epicutaneous routes. Su...
Saved in:
Published in | Allergy asthma & respiratory disease Vol. 12; no. 3; pp. 125 - 133 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한 소아알레르기 호흡기학회
30.07.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 2288-0402 2288-0410 |
DOI | 10.4168/aard.2024.12.3.125 |
Cover
Summary: | Allergen immunotherapy (AIT) has been used for over a century and has been demonstrated to be effective in treating patients with various allergic diseases. AIT allergens can be administered through various routes, including subcutaneous, sublingual, intra-lymphatic, oral, or epicutaneous routes. Sublingual immunotherapy (SLIT) has recently gained clinical interest, and it is considered an alternative treatment for allergic rhinitis (AR) and asthma. This review provides an overview of the current evidence-based studies that address the use of SLIT for treating AR, including (1) mechanisms of action, (2) appropriate patient selection for SLIT, (3) the current available SLIT products in Korea, and (4) updated information on its efficacy and safety. Finally, this guideline aims to provide the clinician with practical considerations for SLIT. |
---|---|
Bibliography: | KISTI1.1003/JNL.JAKO202434472037133 |
ISSN: | 2288-0402 2288-0410 |
DOI: | 10.4168/aard.2024.12.3.125 |